Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles - PubMed (original) (raw)
. 2017 Mar 15:51:471-478.
doi: 10.1016/j.actbio.2017.01.062. Epub 2017 Jan 25.
Affiliations
- PMID: 28131940
- DOI: 10.1016/j.actbio.2017.01.062
Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles
Yue Yan et al. Acta Biomater. 2017.
Abstract
As efficient drug carriers, stimuli-responsive mesoporous silica nanoparticles are at the forefront of research on drug delivery systems. An acid-responsive system based on silyl ether has been applied to deliver a hybrid prodrug. Thiol-ene click chemistry has been successfully utilized for tethering this prodrug to mesoporous silica nanoparticles. Here, by altering the steric bulk of the substituent on the silicon atom, the release rate of a model drug, camptothecin, was controlled. The synthesized drug delivery system was investigated by analytical methods to confirm the functionalization and conjugation of the mesoporous silica nanoparticles. Herein, trimethyl silyl ether and triethyl silyl ether were selected to regulate the release rate. Under normal plasma conditions (pH 7.4), both types of camptothecin-loaded mesoporous silica nanoparticles (i.e., MSN-Me-CPT and MSN-Et-CPT) did not release the model drug. However, under in vitro acidic conditions (pH 4.0), based on a comparison of the release rates, camptothecin was released from MSN-Me-CPT more rapidly than from MSN-Et-CPT. To determine the biocompatibility of the modified mesoporous silica nanoparticles and the in vivo camptothecin uptake behavior, MTT assays with cancer cells and confocal microscopy observations were conducted, with positive results. These functionalized nanoparticles could be useful in clinical treatments requiring controlled drug release.
Statement of significance: As the release rate of drug from drug-carrier plays important role in therapy effects, trimethyl silyl ether (TMS) and triethyl silyl ether (TES) were selected as acid-sensitive silanes to control the release rates of model drugs conjugated from MSNs by thiol-ene click chemistry. The kinetic profiles of TMS and TES materials have been studied. At pH 4.0, the release of camptothecin from MSN-Et-CPT occurred after 2h, whereas MSN-Me-CPT showed immediate drug release. The results showed that silyl ether could be used to control release rates of drugs from MSNs under acid environment, which could be useful in clinical treatments requiring controlled drug release.
Keywords: Click chemistry; Drug delivery; Mesoporous silica nanoparticles; Silyl ether.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
- Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
He H, Xiao H, Kuang H, Xie Z, Chen X, Jing X, Huang Y. He H, et al. Colloids Surf B Biointerfaces. 2014 May 1;117:75-81. doi: 10.1016/j.colsurfb.2014.02.014. Epub 2014 Feb 19. Colloids Surf B Biointerfaces. 2014. PMID: 24632033 - Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery.
Llinàs MC, Martínez-Edo G, Cascante A, Porcar I, Borrós S, Sánchez-García D. Llinàs MC, et al. Drug Deliv. 2018 Nov;25(1):1137-1146. doi: 10.1080/10717544.2018.1472678. Drug Deliv. 2018. PMID: 29779394 Free PMC article. - Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X, Chen L, Yi Z, Li C, He C, Feng C, Wang T, Shigdar S, Duan W, Kong L. She X, et al. Mini Rev Med Chem. 2018;18(11):976-989. doi: 10.2174/1389557516666160505114814. Mini Rev Med Chem. 2018. PMID: 27145854 Review. - Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Slowing II, et al. Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-1288. doi: 10.1016/j.addr.2008.03.012. Epub 2008 Apr 10. Adv Drug Deliv Rev. 2008. PMID: 18514969 Review.
Cited by
- Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X, Xia S, Zhou W, Ji R, Zhan W. Li X, et al. Int J Nanomedicine. 2019 Apr 5;14:2397-2413. doi: 10.2147/IJN.S189252. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31040664 Free PMC article. - Kinetics and Mechanism of Camptothecin Release from Transferrin-Gated Mesoporous Silica Nanoparticles through a pH-Responsive Surface Linker.
Jackson N, Ortiz AC, Jerez A, Morales J, Arriagada F. Jackson N, et al. Pharmaceutics. 2023 May 25;15(6):1590. doi: 10.3390/pharmaceutics15061590. Pharmaceutics. 2023. PMID: 37376039 Free PMC article. - Emerging Progress of RNA-Based Antitumor Therapeutics.
Fu J, Dong H, Wu J, Jin Y. Fu J, et al. Int J Biol Sci. 2023 Jun 19;19(10):3159-3183. doi: 10.7150/ijbs.83732. eCollection 2023. Int J Biol Sci. 2023. PMID: 37416764 Free PMC article. Review. - DDAO Controlled Synthesis of Organo-Modified Silica Nanoparticles with Encapsulated Fluorescent Boron Dipyrrins and Study of Their Uptake by Cancerous Cells.
Goncharenko AA, Tarasyuk IA, Marfin YS, Grzhegorzhevskii KV, Muslimov AR, Bondarenko AB, Lebedev MD, Kuz'min IA, Vashurin AS, Lepik KV, Timin AS, Rumyantsev EV. Goncharenko AA, et al. Molecules. 2020 Aug 21;25(17):3802. doi: 10.3390/molecules25173802. Molecules. 2020. PMID: 32825590 Free PMC article. - Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies.
K P AU, Anil AR, Nair SC, S K K. K P AU, et al. Drug Deliv Transl Res. 2025 Jun 10. doi: 10.1007/s13346-025-01881-1. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 40495092 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous